Should every survivor of a heart attack be given a beta blocker? Part II. Evidence from a clinical pharmacological standpoint.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D006801:Humans; D009203:Myocardial Infarction / Q000517:prevention & control*; D012008:Recurrence; D013997:Time Factors
D000319:Adrenergic beta-Antagonists